Hemoglobin A1c level was a better predictor of the risk of CVD than simply using a diagnosis of diabetes to establish risk, a new analysis of two large cohort studies showed….
Read More »A1c’s May Not Reflect Postpartum Glucose
In women with recent gestational diabetes, alignment of A1c with glucose levels is only “fair”….
Read More »Weight-Based Insulin Dosing Safe at Recommended Doses
Weight-based insulin doses up to 0.6 units per kilogram are associated with a low risk of hypoglycemia, according to a new report….
Read More »Americans Are Flocking to Alternative Therapies
Most Americans believe that prescription medications are the most effective treatments for many common illnesses, but a Consumer Reports survey of more than 45,000 people finds that three-fourths of us are turning to alternative therapies like yoga and acupuncture….
Read More »Dietary Fish Linked to Lower Risk for Type 2 Diabetes in Men
Dietary fish consumption is linked to a lower risk for type 2 diabetes in men but not in women, according to the results of a prospective study.…
Read More »Unintended Glucose Patterns Predict Death
Day-to-day glucose levels that stray too high when tight control is the aim, or too low when therapy isn’t intense, may signal mortality risk, an ACCORD trial subanalysis indicated.…
Read More »U.S. Pediatrician: Take Obese Children and Put in Foster Homes
Boston pediatrician David Ludwig, the center of a media firestorm recently, wants to set the record straight on his view that a state should intervene in the most extreme cases of child obesity.…
Read More »OP-ED: Steps Not Calories
Let’s forget about listing calories on menus and list the time it takes to burn the calories that you are about to order and eat. What if we listed the number of steps or the time needed to burn the calories you are about to eat rather than the calories …
Read More »Why the FDA Said No to First In Class Dapagliflozin
The FDA’s Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) voted 9 to 6 against recommending the approval of the first in class novel antidiabetic agent dapagliflozin, largely because of fears that the product may cause breast and bladder cancer.… The EMDAC panel was also concerned about a lack of pharmacokinetic …
Read More »Hypertriglyceridemia in the Obese is Due to Two Defects
Obesity is a recognized risk factor for heart disease, but it is the location of fat — in the belly or in the liver — that combines to drive metabolic defects that produce hypertriglyceridemia, researchers found.…
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.